Drug profile · INN
eluxadoline
TRUBERZI
eluxadoline (TRUBERZI) is a mu opioid receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — eluxadoline
- US status
- approved
- Class
- Alimentary tract and metabolism (A07)
- Route
- ORAL
- Patents
- 1
- Programs
- 0
- Data quality
- 0.84
Quick answer
eluxadoline (TRUBERZI) is a mu opioid receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Mu opioid receptor agonist
Primary target: Mu-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | withdrawn | — |
Related & competitor drugs
Related patents
Frequently asked questions
What is eluxadoline?
eluxadoline (TRUBERZI) is a mu opioid receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for eluxadoline?
TRUBERZI is a marketed brand name for eluxadoline. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of eluxadoline?
eluxadoline has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.